Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,860 | 52,979 | -76,698 | -205,192 | -142,309 |
| Depreciation Amortization | 649 | 477 | 1,015 | 1,023 | 302 |
| Accounts receivable | -4,094 | -4,612 | 5,323 | -5,382 | -1,067 |
| Accounts payable and accrued liabilities | -910 | 4,090 | 4,474 | -4 | 4,126 |
| Other Working Capital | 867 | 4,728 | 6,018 | 10,578 | -15,227 |
| Other Operating Activity | 8,463 | -66,630 | -10,542 | 52,310 | 49,346 |
| Operating Cash Flow | $-3,885 | $-8,968 | $-70,410 | $-146,667 | $-104,829 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 8,233 |
| PPE Investments | -569 | -4 | -341 | -2,939 | -2,254 |
| Net Acquisitions | N/A | N/A | N/A | 250 | 250 |
| Investing Cash Flow | $-569 | $-4 | $-341 | $-2,689 | $6,229 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 397 | 5,640 | 11,500 | N/A | 50,000 |
| Debt Repayment | -782 | -1,154 | -5,892 | N/A | N/A |
| Common Stock Issued | N/A | 290 | 57,551 | 81,990 | 107,968 |
| Common Stock Repurchased | N/A | N/A | -18 | N/A | N/A |
| Other Financing Activity | 5,000 | 0 | -1,202 | 8,703 | -3,742 |
| Financing Cash Flow | $4,615 | $4,776 | $61,939 | $90,693 | $154,226 |
| Beginning Cash Position | 580 | 4,776 | 13,588 | 72,251 | 16,625 |
| End Cash Position | 741 | 580 | 4,776 | 13,588 | 72,251 |
| Net Cash Flow | $161 | $-4,196 | $-8,812 | $-58,663 | $55,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,885 | -8,968 | -70,410 | -146,667 | -104,829 |
| Capital Expenditure | -569 | -4 | -341 | -2,939 | -2,254 |
| Free Cash Flow | -4,454 | -8,972 | -70,751 | -149,606 | -107,083 |